These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7854391)

  • 1. Prophylactic immune globulin in children with HIV disease.
    Mofenson LM; Nugent R
    N Engl J Med; 1995 Mar; 332(11):750-2. PubMed ID: 7854391
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home infusion of intravenous immune globulin in human immunodeficiency virus-infected children.
    Poole JK
    J Intraven Nurs; 1993; 16(1):18-22. PubMed ID: 8437042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of intravenous 7S immunoglobulins at high doses in HIV-related immunological pathology].
    Fiori GP
    Clin Ter; 1994 Apr; 144(4):301-5. PubMed ID: 8205754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does intravenous immune globulin have a role in HIV-infected patients?
    Yap PL
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis against Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus.
    CDR (Lond Engl Wkly); 1991 Apr; 1(15):65. PubMed ID: 1669802
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa.
    ;
    Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907
    [No Abstract]   [Full Text] [Related]  

  • 9. [Exanthema in multiple therapy in HIV infection].
    Weisser M
    Praxis (Bern 1994); 1998 May; 87(20):702-4. PubMed ID: 9633229
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing a patient with progressive HIV disease.
    Blais FX
    J Am Osteopath Assoc; 1992 Oct; 92(10):1267-8. PubMed ID: 1459873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding prophylactic therapy for HIV infections.
    Anastasi JK; Rivera J
    Am J Nurs; 1994 Feb; 94(2):36-41; quiz 42. PubMed ID: 8304396
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection.
    Kovacs JA; Masur H
    N Engl J Med; 2000 May; 342(19):1416-29. PubMed ID: 10805828
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of trimethoprim-sulphamethoxazole in preventing HIV-associated bacteraemia.
    Tumbarello M; Tacconelli E; Cauda R; Ortona L
    AIDS; 1997 Jul; 11(8):1070-1. PubMed ID: 9223752
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M; Stephenson K; Gauar S; Frenkel L
    Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa?
    Samb B; Badiane M; Kony S; Larouzé B; Faye MA; Sow PS; Badiane S; Metro A; Costagliola D; Ndoye I; Delaporte E; Coll-Seck AM; Coulaud JP
    AIDS; 1998 Mar; 12(4):447. PubMed ID: 9520181
    [No Abstract]   [Full Text] [Related]  

  • 16. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in infants.
    Mueller BU; Pizzo PA
    Pediatr Infect Dis J; 1992 Dec; 11(12):1072-3. PubMed ID: 1461709
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumocystis carinii pneumonia (PCP) in HIV-infected African children.
    Zar HJ
    SADJ; 2001 Dec; 56(12):617-9. PubMed ID: 11887451
    [No Abstract]   [Full Text] [Related]  

  • 19. [Update on consensual proposals (1993 February). Role of cotrimoxazole in the primary prevention of toxoplasmosis in patients with HIV infection].
    Leport C; Ambroise-Thomas P; Chêne G; Derouin F; Katlama C; Raffi F; Vildé JL
    Ann Med Interne (Paris); 1993; 144(1):56-7. PubMed ID: 8503612
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevention and treatment of opportunistic infections in HIV-infected adults.
    HIV Clinician Society of Southern Africa
    S Afr Med J; 2002 Jun; 92(6):426-8. PubMed ID: 12146122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.